Mercer Global Advisors Portfolio holdings
AUM
$44.5B
1-Year Return
12.22%
This Quarter Return
+5.58%
1 Year Return
+12.22%
3 Year Return
+48.64%
5 Year Return
+80.05%
10 Year Return
–
AUM
$13B
AUM Growth
+$2.01B
(+18%)
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
10.95%
Top 10 Holdings %
Top 10 Hldgs %
25.45%
Holding
1,778
New
161
Increased
970
Reduced
480
Closed
112
Top Buys
| 1 |
Dimensional US Equity ETF
DFUS
|
$181M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
$134M |
| 3 |
Dimensional US Targeted Value ETF
DFAT
|
$80.8M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
$67.1M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
$66.3M |
Top Sells
| 1 |
iShares Gold Trust
IAU
|
$19.9M |
| 2 |
Verizon
VZ
|
$7.85M |
| 3 |
SPDR Portfolio S&P 500 Value ETF
SPYV
|
$7.67M |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
$7.08M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$6.25M |
Sector Composition
| 1 | Technology | 8.75% |
| 2 | Financials | 4.71% |
| 3 | Consumer Discretionary | 3.99% |
| 4 | Healthcare | 3.72% |
| 5 | Industrials | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
PG&E
PCG
$33.5B
| $135K | ﹤0.01% |
13,280
+403
| +3% | +$4.1K |
|
1602
Summit Therapeutics
SMMT
$17.7B
| $134K | ﹤0.01% |
17,950
+1,000
| +6% | +$7.47K |
|
1603
Empire State Realty Trust
ESRT
$1.33B
| $132K | ﹤0.01% |
+10,997
| New | +$132K |
|
|
BWG
1604
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$146M
| $130K | ﹤0.01% |
10,288
| – | – |
|
1605
ReposiTrak
TRAK
$307M
| $127K | ﹤0.01% |
23,021
-5,500
| -19% | -$30.3K |
|
1606
Gabelli Equity Trust
GAB
$1.89B
| $126K | ﹤0.01% |
18,221
+4,295
| +31% | +$29.7K |
|
1607
Cemex
CX
$13.4B
| $125K | ﹤0.01% |
14,828
-3,581
| -19% | -$30.2K |
|
1608
Carisma Therapeutics
CARM
$13.4M
| $124K | ﹤0.01% |
1,338
+171
| +15% | +$15.8K |
|
1609
FNB Corp
FNB
$6.03B
| $123K | ﹤0.01% |
+10,005
| New | +$123K |
|
1610
Invesco Senior Income Trust
VVR
$555M
| $122K | ﹤0.01% |
27,389
+26
| +0.1% | +$116 |
|
|
MFA
1611
MFA Financial
MFA
$1.07B
| $119K | ﹤0.01% |
6,505
-32
| -0.5% | -$585 |
|
|
ATAXZ
1612
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $117K | ﹤0.01% |
17,300
| – | – |
|
1613
Polaris
PII
$3.26B
| $110K | ﹤0.01% |
800
| – | – |
|
1614
KALA BIO
KALA
$102M
| $108K | ﹤0.01% |
+408
| New | +$108K |
|
1615
ImmuCell
ICCC
$59M
| $106K | ﹤0.01% |
11,202
| – | – |
|
1616
Liberty All-Star Equity Fund
USA
$1.95B
| $106K | ﹤0.01% |
11,717
-8,600
| -42% | -$77.8K |
|
1617
Lloyds Banking Group
LYG
$64.9B
| $105K | ﹤0.01% |
41,212
+1,123
| +3% | +$2.86K |
|
1618
ASE Group
ASX
$22.4B
| $104K | ﹤0.01% |
12,881
+659
| +5% | +$5.32K |
|
|
ZEV
1619
DELISTED
Lightning eMotors, Inc.
ZEV
| $104K | ﹤0.01% |
625
| – | – |
|
1620
Riverview Bancorp
RVSB
$101M
| $102K | ﹤0.01% |
14,384
+210
| +1% | +$1.49K |
|
|
VIEW
1621
DELISTED
View, Inc. Class A Common Stock
VIEW
| $98K | ﹤0.01% |
192
| – | – |
|
1622
Oaktree Specialty Lending
OCSL
$1.22B
| $94K | ﹤0.01% |
4,676
-2,935
| -39% | -$59K |
|
1623
Genworth Financial
GNW
$3.55B
| $93K | ﹤0.01% |
+23,744
| New | +$93K |
|
|
VIOT
1624
Viomi Technology
VIOT
$212M
| $92K | ﹤0.01% |
10,827
+648
| +6% | +$5.51K |
|
1625
DigitalBridge
DBRG
$2.05B
| $89K | ﹤0.01% |
2,829
| – | – |
|